Active Ingredient: NEOSTIGMINE METHYLSULFATE
Proprietary Name: NEOSTIGMINE METHYLSULFATE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 5MG/10ML (0.5MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A213244
Product Number: 001
Approval Date: Nov 2, 2023
Applicant Holder Full Name: EUGIA PHARMA SPECIALITIES LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
Active Ingredient: NEOSTIGMINE METHYLSULFATE
Proprietary Name: NEOSTIGMINE METHYLSULFATE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 10MG/10ML (1MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A213244
Product Number: 002
Approval Date: Nov 2, 2023
Applicant Holder Full Name: EUGIA PHARMA SPECIALITIES LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information